TSG's Laurie Clarke, along with Rob Morgan and Eduardo von Ristow from our sister company Sagentia Innovation, take part in this panel discussion focusing on real issues faced by those involved in developing, assuring compliance and quality, investing in, and marketing medical devices. The team answers questions on how to navigate the 510(k), de novo, and PMA routes to market, translating concepts into products and maximizing success by better understanding different stakeholders' needs, technology feasibility and commercial viability.

Watch the panel discussion below and email us at [email protected] if you have any further questions.